Stablepharma’s Fridge-Free Vaccine Booster on Track for Clinical Trial in the UK 2 years ago AnaIn Innovation
Vertex Taps Orna Therapeutics’ Lipid Nanoparticle Technology to Advance Gene Editing for Blood Disorders 2 years ago AnaIn PartnershipsPeoplePharma Industry Updates
Cyprium’s CUTX-101 Secures FDA Priority Review: A Defining Moment for Menkes Disease Treatment 2 years ago AnaIn Biopharma HighlightsClinical TrialsFDA Approvals
Vertex and Moderna Launch First-In-Human Inhaled mRNA Candidate for Cystic Fibrosis 2 years ago AnaIn Clinical TrialsInnovation
Rentosertib: The First Fully AI-Designed Drug Enters Mid-Stage Trials for Pulmonary Fibrosis 2 years ago AnaIn AI & DataBreaking NewsInnovation
Datopotamab Deruxtecan Earns U.S. Approval, Opens New Chapter in Breast Cancer Therapy 2 years ago AnaIn FDA ApprovalsResearch UpdatesTop Stories
Neumora’s Depression Drug Stumbles in Pivotal Phase 3, Stock Plummets Over 80% 2 years ago AnaIn Clinical TrialsInvestmentsResearch UpdatesTop Stories
FDA and EMA Forge Path for Faster Huntington’s Therapy Approvals in Wake of uniQure Breakthrough 2 years ago AnaIn BreakthroughsFDA Approvals
AI-Based ECG Tool Earns Medicare Coverage, Ushering in New Era for Atrial Fibrillation Screening 2 years ago AnaIn AI & DataBreakthroughsTop Stories
End-of-Year Breakthroughs Fuel Optimism in Clinical Research 2 years ago AnaIn BreakthroughsClinical Trials
New Venture Capital Firms Step In to Fuel Clinical Research Amid Biotech Funding Shift 2 years ago AnaIn Funding RoundsInvestmentsPeopleVenture Capital
NHS Launches World-First AI Tool to Predict Type 2 Diabetes Risk From ECG Readings 2 years ago AnaIn InnovationLeaders
Australia Trials Novel AI-Guided Brain Stimulation for Treatment-Resistant Depression 2 years ago AnaIn AI & DataInnovationTop Stories
Clinical Trials in 2025 Face a Tug-of-War Between Innovation, Costs, and Regulation 2 years ago AnaIn Clinical Trials
Beyond Weight Loss: GLP-1 Agonists Show Promise Across Neurological, Cardiovascular, and Renal Diseases 2 years ago AnaIn Breaking NewsInnovationResearch UpdatesTop Stories
